Tuesday September 15, 1200-1300 (UTC)

Sanne Kloosterboer, Erasmus MC, Netherlands
Birgit Koch, Erasmus MC, Netherlands
George Schoretsanitis, Zucker Hillside Hospital, USA

Learning Objectives: At the end of this session participants will be able to:
- Describe the current opinion of TDM of antipsychotics in general.
- Explain what is the PK of antipsychotics in children and when to do TDM in this population.
- Discuss what is the PK and the added value of TDM in pregnant patients with regard to antipsychotics and antidepressants.

Question Title

* 1. This session overall

  Disagree Neutral Agree Strongly Agree
Sufficient time was allowed for audience participation/active learning
The session was free from commercial bias

Question Title

* 2. Overall, I would rate this symposium as:

Question Title

* 3. Speaker: Sanne Kloosterboer

  Fair Good Very Good Outstanding
Knowledgeable, organized and effective
Educational content/Relevance to practice
Balanced and unbiased

Question Title

* 4. Speaker: Birgit Koch

  Fair Good Very Good Outstanding
Knowledgeable, organized and effective
Educational content/Relevance to practice
Balanced and unbiased

Question Title

* 5. Speaker: George Schoretsanitis

  Fair Good Very Good Outstanding
Knowledgeable, organized and effective
Educational content/Relevance to practice
Balanced and unbiased

Question Title

* 6. As a result of attending this session, I am planning to:

Question Title

* 7. Please explain any changes you plan to make or personal learning projects you will pursue as a result of this session:

Question Title

* 8. What topics would you like to be addressed at future conferences to keep you up to date in your profession?

T